Humedix Co., Ltd. (KOSDAQ:200670)
South Korea · Delayed Price · Currency is KRW 50,500
-700 (-1.37%)
Oct 10, 2025, 3:30 PM KST
Humedix Market Cap
Humedix has a market cap or net worth of 521.17 billion as of October 10, 2025. Its market cap has increased by 59.42% in one year.
Market Cap
521.17B
Enterprise Value
n/a
Revenue
110.99B
Ranking
n/a
PE Ratio
52.39
Stock Price
50,500.00
Market Cap Chart
Since December 26, 2014, Humedix's market cap has increased from 223.01B to 521.17B, an increase of 133.70%. That is a compound annual growth rate of 8.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2025 | 528.39B | 21.32% |
| Dec 30, 2024 | 435.54B | 24.67% |
| Dec 28, 2023 | 349.36B | 38.28% |
| Dec 29, 2022 | 252.65B | 12.18% |
| Dec 30, 2021 | 225.21B | -0.11% |
| Dec 30, 2020 | 225.47B | 2.25% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 71.81T |
| Celltrion | 38.64T |
| ALTEOGEN | 25.22T |
| Yuhan | 8,969.60B |
| SK Biopharmaceuticals | 8,144.58B |
| Peptron | 7,006.86B |
| PharmaResearch | 5,714.31B |
| LigaChem Biosciences | 5,545.53B |